Stock Events

Stock Events

Adhera Therapeutics 

$0.000100
2
+$0.00+0% Wednesday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.01
52W Low
0.0001
Volume
84,001
Avg. Volume
122
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.57
-0.38
-0.19
0
Expected EPS
0
Actual EPS
-0.57

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-2.73MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech company that develops treatments in areas that may overlap with Adhera's focus on cardiovascular diseases, making them direct competitors in the biopharmaceutical market.
Pfizer
PFE
Mkt Cap159.36B
Pfizer operates in various therapeutic areas, including cardiovascular health, directly competing with Adhera Therapeutics in the pharmaceutical market.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that offers products in multiple segments, including cardiovascular, competing with Adhera's product offerings.
Merck
MRK
Mkt Cap366B
Merck is known for its wide range of pharmaceutical products, including treatments for cardiovascular diseases, positioning it as a competitor to Adhera Therapeutics.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences focuses on life-threatening diseases, including cardiovascular conditions, making it a competitor in the same therapeutic area as Adhera.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in various therapeutic areas, including cardiovascular health, competing with Adhera Therapeutics in the biopharmaceutical space.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb offers a range of prescription medicines, including those for cardiovascular diseases, directly competing with Adhera Therapeutics.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is involved in the discovery, development, and commercialization of prescription medicines, including for cardiovascular diseases, making it a competitor to Adhera.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment, develops treatments for various diseases, including cardiovascular, competing with Adhera Therapeutics.
Sanofi
SNY
Mkt Cap107.39B
Sanofi focuses on healthcare solutions, including cardiovascular diseases, positioning it as a competitor in the same market as Adhera Therapeutics.

About

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Show more...
CEO
David A. Battat
Employees
2
Country
United States
ISIN
US00687E4061

Listings

OTC Link
US
ATRX

0 Comments

Share your thoughts

FAQ

What is Adhera Therapeutics stock price today?▼
The current price of ATRX is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Adhera Therapeutics stock price performance more closely on the chart.
What is Adhera Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Adhera Therapeutics stocks are traded under the ticker ATRX.
Is Adhera Therapeutics stock price growing?▼
ATRX stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Adhera Therapeutics has showed a -99% decrease.
What were Adhera Therapeutics earnings last quarter?▼
ATRX earnings for the last quarter are -0.57 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Adhera Therapeutics revenue for the last year?▼
Adhera Therapeutics revenue for the last year amounts to 0 USD.
What is Adhera Therapeutics net income for the last year?▼
ATRX net income for the last year is -2.73M USD.
How many employees does Adhera Therapeutics have?▼
As of September 04, 2026, the company has 2 employees.
In which sector is Adhera Therapeutics located?▼
Adhera Therapeutics operates in the Health & Wellness sector.
When did Adhera Therapeutics complete a stock split?▼
The last stock split for Adhera Therapeutics was on October 06, 2022 with a ratio of 1:20.
Where is Adhera Therapeutics headquartered?▼
Adhera Therapeutics is headquartered in Baton Rouge, United States.